What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His scientific interests lie mostly in Intensive care medicine, Internal medicine, COPD, Mechanical ventilation and Intensive care.
His Intensive care medicine research is multidisciplinary, relying on both Incidence, MEDLINE, Pneumonia, Pulmonary disease and Spirometry.
His COPD research includes elements of Exacerbation, Physical therapy, Severity of illness and Pulmonary function testing.
His work deals with themes such as Prospective cohort study, Cohort study and Intensive care unit, which intersect with Mechanical ventilation.
His Intensive care research incorporates themes from Acute exacerbation of chronic obstructive pulmonary disease, Septic shock, Shock and Emergency medicine.
His Acute exacerbation of chronic obstructive pulmonary disease course of study focuses on Lung emphysema and Public health.
His most cited work include:
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (14328 citations)
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults (4495 citations)
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper (3605 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Intensive care medicine, COPD, Pneumonia and Exacerbation.
His studies deal with areas such as Gastroenterology and Surgery as well as Internal medicine.
The study incorporates disciplines such as Community-acquired pneumonia, Mechanical ventilation, Cohort study and Antibiotics in addition to Intensive care medicine.
His Mechanical ventilation research is multidisciplinary, incorporating elements of Prospective cohort study, Intensive care, Cohort and Emergency medicine.
Antonio Anzueto interconnects Pulmonary disease, Physical therapy, Disease and Hazard ratio in the investigation of issues within COPD.
In Pneumonia, Antonio Anzueto works on issues like Odds ratio, which are connected to Confidence interval.
He most often published in these fields:
- Internal medicine (48.48%)
- Intensive care medicine (42.08%)
- COPD (36.16%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (48.48%)
- COPD (36.16%)
- Exacerbation (18.08%)
In recent papers he was focusing on the following fields of study:
Internal medicine, COPD, Exacerbation, Intensive care medicine and In patient are his primary areas of study.
His work focuses on many connections between Internal medicine and other disciplines, such as Gastroenterology, that overlap with his field of interest in Budesonide and Metered-dose inhaler.
His COPD research focuses on Obstructive lung disease in particular.
As a member of one scientific family, he mostly works in the field of Exacerbation, focusing on Adverse effect and, on occasion, Randomized controlled trial.
His Intensive care medicine research integrates issues from Quality of life, Pulmonary disease, Guideline, Increased risk and Initial treatment.
His study in Confidence interval is interdisciplinary in nature, drawing from both Odds ratio and Intensive care unit.
Between 2017 and 2021, his most popular works were:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 (472 citations)
- Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial. (89 citations)
- Pneumonia in Patients with Chronic Obstructive Pulmonary Disease (37 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
His primary areas of investigation include COPD, Internal medicine, Intensive care medicine, In patient and Exacerbation.
He studies COPD, namely Obstructive lung disease.
His Internal medicine research focuses on Antibiotics and how it connects with Drug resistance, Prevalence and Logistic regression.
His Intensive care medicine study incorporates themes from Bronchodilator and Quality of life.
His Exacerbation study integrates concerns from other disciplines, such as Treatment Setting, Primary care and Optimal management.
His work on Community-acquired pneumonia as part of general Pneumonia research is frequently linked to Atypical antipsychotic, thereby connecting diverse disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
